The present invention relates to novel compounds that are {HEAD ~ inhibitors} of wild type and mutant dihydrofolate reductase of Plasmodium falciparum, which are useful for {TAIL ~ the treatment} of malaria 
The present invention relates to novel compounds that are { HEAD ~ inhibitors } of wild type and mutant dihydrofolate reductase of Plasmodium falciparum , which are useful for { TAIL ~ the treatment } of malaria
OTH OTH OTH OTH OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH